SMAD5 and chronic obstructive pulmonary disease: In patients with COPD, there is a shift in energy metabolism from oxidative phosphorylation to glycolysis or the PPP, and oxidative stress causes excessive intracellular production of acidic metabolites, which might lead to alterations in pHi and thus affect the nucleoplasmic distribution of Smad5.